相似文献
1
Effectiveness of Tocilizumab in Patients Hospitalized With COVID-19: A Follow-up of the CORIMUNO-TOCI-1 Randomized Clinical Trial.
JAMA Intern Med. 2021 Sep 1;181(9):1241-1243. doi: 10.1001/jamainternmed.2021.2209.
2
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.
3
Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):468. doi: 10.1186/s13063-020-04453-5.
4
Efficacy of tocilizumab treatment in severely ill COVID-19 patients.
Crit Care. 2020 Aug 27;24(1):524. doi: 10.1186/s13054-020-03224-7.
5
The COVIRL002 Trial-Tocilizumab for management of severe, non-critical COVID-19 infection: A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Sep 3;21(1):758. doi: 10.1186/s13063-020-04680-w.
6
[COVID-19: Still a place for tocilizumab?].
Rev Med Interne. 2021 Feb;42(2):73-78. doi: 10.1016/j.revmed.2020.11.016. Epub 2020 Nov 27.
7
A prospective, randomised, double blind placebo-controlled trial to evaluate the efficacy and safety of tocilizumab in patients with severe COVID-19 pneumonia (TOC-COVID): A structured summary of a study protocol for a randomised controlled trial.
Trials. 2020 Jun 3;21(1):470. doi: 10.1186/s13063-020-04447-3.
8
Profiling COVID-19 pneumonia progressing into the cytokine storm syndrome: Results from a single Italian Centre study on tocilizumab versus standard of care.
J Clin Virol. 2020 Aug;129:104444. doi: 10.1016/j.jcv.2020.104444. Epub 2020 May 15.
9
Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational study.
PLoS One. 2020 Aug 13;15(8):e0237693. doi: 10.1371/journal.pone.0237693. eCollection 2020.
10
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia.
Clin Pharmacol Ther. 2021 Mar;109(3):688-696. doi: 10.1002/cpt.2117. Epub 2020 Dec 10.
引用本文的文献
1
Global maternal mortality associated with SARS-CoV-2 infection: a systematic review and meta-analysis.
BMJ Glob Health. 2025 Apr 21;10(4):e015815. doi: 10.1136/bmjgh-2024-015815.
2
Senescence as a therapeutic target in cancer and age-related diseases.
Nat Rev Drug Discov. 2025 Jan;24(1):57-71. doi: 10.1038/s41573-024-01074-4. Epub 2024 Nov 15.
3
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients.
Intensive Care Med. 2024 Nov;50(11):1884-1896. doi: 10.1007/s00134-024-07593-3. Epub 2024 Aug 26.
4
COVID-19 Pneumonia and Cytokine Storm Syndrome.
Adv Exp Med Biol. 2024;1448:307-319. doi: 10.1007/978-3-031-59815-9_22.
5
Tocilizumab demonstrates superiority in decreasing C-reactive protein levels in hospitalized COVID-19 patients, compared to standard care treatment alone.
Microbiol Spectr. 2024 Jun 4;12(6):e0249823. doi: 10.1128/spectrum.02498-23. Epub 2024 Apr 30.
6
The clinical features, treatment and prognosis of neutropenic fever and Coronavirus disease 2019 results of the multicentre teos study.
Sci Rep. 2024 Mar 3;14(1):5218. doi: 10.1038/s41598-024-55886-w.
7
Application of LRG mechanism in normal pressure hydrocephalus.
Heliyon. 2023 Dec 16;10(1):e23940. doi: 10.1016/j.heliyon.2023.e23940. eCollection 2024 Jan 15.
8
Inhaled beclomethasone in the treatment of early COVID-19: a double-blind, placebo-controlled, randomised, hospital-based trial in Sri Lanka.
BMJ Open. 2023 Dec 14;13(12):e075803. doi: 10.1136/bmjopen-2023-075803.
9
Tocilizumab in ICU-admitted COVID-19 Patients: A Retrospective Study.
Med J Islam Repub Iran. 2023 Aug 28;37:92. doi: 10.47176/mjiri.37.92. eCollection 2023.
10
High-CBD cannabis extracts inhibit the expression of proinflammatory factors via miRNA-mediated silencing in human small intestinal epithelial cells.
Heliyon. 2023 Aug 5;9(8):e18817. doi: 10.1016/j.heliyon.2023.e18817. eCollection 2023 Aug.
本文引用的文献
1
Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19.
N Engl J Med. 2021 Apr 22;384(16):1491-1502. doi: 10.1056/NEJMoa2100433. Epub 2021 Feb 25.
2
Tocilizumab in Patients Hospitalized with Covid-19 Pneumonia.
N Engl J Med. 2021 Jan 7;384(1):20-30. doi: 10.1056/NEJMoa2030340. Epub 2020 Dec 17.
3
Efficacy of Tocilizumab in Patients Hospitalized with Covid-19.
N Engl J Med. 2020 Dec 10;383(24):2333-2344. doi: 10.1056/NEJMoa2028836. Epub 2020 Oct 21.
4
Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia: A Randomized Clinical Trial.
JAMA Intern Med. 2021 Jan 1;181(1):32-40. doi: 10.1001/jamainternmed.2020.6820.
5
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia: A Randomized Clinical Trial.
JAMA Intern Med. 2021 Jan 1;181(1):24-31. doi: 10.1001/jamainternmed.2020.6615.
Zotero 插件